Daniel Morillo, MD

Hematologist & Clinical Investigator

Clinical Trials Ran
0 +

Daniel Morillo M.D., is a Hematologist consultant dedicated to clinical research at START Madrid-FJD.He obtained his Medical Degree by the University Complutense of Madrid in 2009 and completed his specialized formation in Hematology and Hemotherapy at Hospital Universitario Puerta de Hierro, Madrid during 2010 and 2014.

Before finishing his residency, he spent two months in 2013 as Observer Physician, in the Department of Bone Marrow Trasplantation at Memorial Sloan Kattering Cancer Center, New York. Upon completing his residency in 2014, he started a new challenge, creating and developing the Hematology Service at Hospital General de Villalba, Madrid.

In 2017, Dr. Morillo decided to focus his career in hemato-oncology clinical investigation and he joined the START Program as a Clinical Researcher dedicated to Early Phase Trials.

He is currently an active Investigator in more than 30 trials (both early phase and phase-3 trials), and has been a co-author of several scientific papers published in medical journals. He is also consultant at the Lymphoma and Myeloma Unit at Oncohealth Institute, Fundación Jiménez Díaz and a member of the Spanish Society of Hematology.

Areas of Expertise

Hematology (Multiple Myeloma, Acute Myeloid Leukemia, Cell Therapy)



Journal: Oncotarget

Published Date: August 7, 2023


Journal: Blood

Published Date: April 27, 2023


Journal: Expert Rev Hematol.

Published Date: December 4, 2020


Journal: American Cancer Society Journal

Published Date: June 2, 2020